比亞迪(01211.HK)與烏茲別克投資工業與貿易部簽署投資協定
比亞迪(01211.HK)公布,上月底與烏茲別克投資工業與貿易部簽署投資協議,烏茲別克投資工業與貿易部將為比亞迪與UZAVTOSANOAT JSC(UzAuto)的合資企業在整車和零部件生產等方面提供政策支援。
比亞迪去年12月與UzAuto簽署協議,在烏茲別克吉札克州成立合資公司「比亞迪烏茲別克工廠」(BYD Uzbekistan Factory ),用於生產新能源汽車及相關零件,計劃於2024年投產,生產驅逐艦和宋兩款暢銷車型。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.